Phase 1 study of SGN-B7H4V, a novel, investigational vedotin antibody-drug conjugate directed to B7-H4, in patients with advanced solid tumors (SGNB7H4V001, trial in progress)

被引：0

作者：

Patnaik, Amita

Lakhani, Nehal J.

Xu, Ping

Nazarenko, Natalya N.

Call, Justin A.

机构：

[1] START San Antonio, San Antonio, TX USA

[2] START Midwest, Grand Rapids, MI USA

[3] Seagen Inc, Bothell, WA USA

[4] START Mt Reg, Salt Lake City, UT USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS3155

引用

页数：1